Subtype
Bone Neoplasm
CI-CAN-00000569Explore in graph →
Non-malignant65 active trials4 approved drugs16 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000569Explore in graph →
Clinical trials
342 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00095017 | Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083) | withdrawn | Phase 2 | 0 | Organon and CoINDUSTRY | 0 | Feb 16, 2022 | clinicaltrials |
| NCT05116800 | Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma | withdrawn | Phase 2 | 0 | Brown UniversityOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT04906876 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas |
| withdrawn |
| Phase 2 |
| 0 |
| Brown UniversityOTHER |
| 1 |
| Jul 28, 2021 |
| clinicaltrials |
| NCT00478270 | A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. | withdrawn | Phase 2 | 0 | Hoffmann-La RocheINDUSTRY | 1 | Aug 16, 2017 | clinicaltrials |
| NCT00851162 | Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions | withdrawn | Phase 2 / Phase 3 | 0 | Emory UniversityOTHER | 1 | Nov 28, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Feb 16, 2022source: clinicaltrials